Clinical Trial

Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS

Study acronym: PCOS OID
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 16, 2025 (before its estimated January 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
Does combined Cabergoline and letrozole increase ovulation rate What medical problems do participants have when taking drug Cabergoline and Letrozole ? Researchers will compare drug combination of Cabergoline and letrozole to letrozole alone to see combined cabergoline and letrozole works better as ovulation induction. Participants will: experimental group will receive Cabergoline and Letrozole comparator group will receive letrozole alone TVS Monitoring will be done for 3 cycle for ovarian response
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-20.
Trial Details
NCT Number NCT07255911
Lead Sponsor Mst.Sumyara Khatun
Collaborators: Bangladesh Medical University
Conditions PCOS
Enrollment 72 participants
Start Date 2025-02-07
Primary Completion 2026-01-06 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-16